AKT1 and seborrheic dermatitis: Therefore, the modulation of proinflammatory cytokine secretion and altered Akt/mTOR signaling is an attractive avenue to discover therapies for skin cancer and inflammatory skin diseases, including eczema, seborrheic dermatitis, and psoriasis.